Professor Admire Dube, an accomplished academic at the University of the Western Cape (UWC), has been appointed to the World Health Organisation (WHO) Expert Advisory Panel on International Pharmacopoeia and Pharmaceutical Preparations.
Prof Dube, who serves as an Associate Professor in the School of Pharmacy and holds the position of Deputy Dean for Learning and Teaching for the Faculty of Natural Sciences, specialises in the formulation of medicines and the development of new drug delivery systems for infectious diseases.
In his new role, Prof Dube will be providing invaluable advice to the WHO on standards and guidelines for drugs and medicines. He will contribute technical information on developments in his field, and provide advice as appropriate, spontaneously or upon request by the WHO.
Prof Dube explained what this means: “When we look at the International Pharmacopoeia, this is essentially a book which describes the quality requirements of drugs and medicines. For example, there is a monograph on paracetamol, and paracetamol must meet these standards – then it’s considered a good quality paracetamol”. These pharmacopoeial requirements form the basis for establishing quality standards for pharmaceuticals, which are to be followed by manufacturers and those who procure medicines to achieve global uniformity of quality, safe and efficacious medicines.
Prof Dube sees his appointment to the advisory panel as a notable role, not only for himself but also for UWC students and other staff members. He said: “I can see the benefits of my role on this panel to learning, teaching and research in the School of Pharmacy and UWC in general”. This appointment, which commenced in August 2023 and spans a four-year term, places Prof Dube at the forefront of developments in the pharmaceutical industry, particularly in relation to new medicines.
This achievement is not only a reflection of Prof Dube’s expertise and dedication but also elevates the standing of the University of the Western Cape on the global stage. His contribution to the WHO’s Expert Advisory Panel will undoubtedly shape the future of the pharmaceutical standards and enhance the quality and safety of medicines worldwide.
